Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
A. J. P. M. Smout, W. P. Geus, P. G. H. Mulder, R. W. Stockbrügger & C. B. H. W. Lamers. (1996) Gastro-oesophageal Reflux Disease in the Netherlands. Results of a Multicentre pH Study. Scandinavian Journal of Gastroenterology 31:sup218, pages 10-15.
Read now
Read now
J. G. Hatlebakk & A. Berstad. (1996) Gastro-Oesophageal Reflux during 3 Months of Therapy with Ranitidine in Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 31:10, pages 954-958.
Read now
Read now
E. C. Klinkenberg-Knol. (1991) Recent Advances in the Management of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 26:sup188, pages 101-107.
Read now
Read now
G. N. J. Tytgat, C. Y. Nio & R. H. Schotborgh. (1990) Reflux Esophagitis. Scandinavian Journal of Gastroenterology 25:sup175, pages 1-12.
Read now
Read now
C. B. H. W. Lamers. (1989) Therapeutic Options in Severe Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 24:sup171, pages 133-135.
Read now
Read now
Articles from other publishers (11)
Jansen & Van Oene. (2001) Standard‐dose lansoprazole is more effective than high‐dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. Alimentary Pharmacology & Therapeutics 13:12, pages 1611-1620.
Crossref
Crossref
Orr & Harnish. (1998) Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Alimentary Pharmacology & Therapeutics 12:10, pages 1033-1038.
Crossref
Crossref
W. C. ORR, M. H. MELLOW & M. R. GROSSMAN. (2007)
Patterns of 24‐hour oesophageal acid exposure after acute withdrawal of acid suppression
. Alimentary Pharmacology & Therapeutics 9:5, pages 571-574.
Crossref
Crossref
A. B. R. THOMSON, L. BABIUK, P. KIRDEIKIS, L. ZUK, B. MARRIAGE & K. BOWES. (2007) A dose‐ranging study of ranitidine and its effect on intragastric and intra‐oesophageal acidity in subjects with gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 8:4, pages 443-451.
Crossref
Crossref
A. G. Fraser, A. M. Sawyerr, M. Hudson, M. Smith & R. E. Pounder. (1994) Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration. Digestive Diseases and Sciences 39:1, pages 91-96.
Crossref
Crossref
I. C. E. Wesdorp, W. Dekker & H. P. M. Festen. (1993) Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis. Digestive Diseases and Sciences 38:12, pages 2287-2293.
Crossref
Crossref
J. P. Galmiche, S. Bruley Des Varannes & C. Scarpignato. 1993. Der Magen. Der Magen
255
271
.
J. P. Galmiche, S. Bruley des Varannes & C. Scarpignato. 1993. The Stomach. The Stomach
234
248
.
W. ROUFAIL, A. BELSITO, M. ROBINSON, C. BARISH & A. RUBIN. (2007) Ranitidine for erosive oesophagitis: a double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics 6:5, pages 597-607.
Crossref
Crossref
J. RUSSELL, W. C. ORR, T. WILSON & A. L. FINN. (2007) Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Alimentary Pharmacology & Therapeutics 5:6, pages 621-630.
Crossref
Crossref
N. J. JOHNSON, E. J. S. BOYD, J. G. MILLS & J. R. WOOD. (2007) Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.. Alimentary Pharmacology & Therapeutics 3:3, pages 259-266.
Crossref
Crossref